Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Calculi Dissolution Agent [EPC]
Paraffin is a multifaceted therapeutic agent primarily classified as a Calculi Dissolution Agent [EPC]. It is utilized in various clinical settings for its acidifying and calcium-chelating properties to manage metabolic and urological conditions.
Name
Paraffin
Raw Name
PARAFFIN
Category
Calculi Dissolution Agent [EPC]
Drug Count
9
Variant Count
9
Last Verified
February 17, 2026
About Paraffin
Paraffin is a multifaceted therapeutic agent primarily classified as a Calculi Dissolution Agent [EPC]. It is utilized in various clinical settings for its acidifying and calcium-chelating properties to manage metabolic and urological conditions.
Detailed information about Paraffin
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Paraffin.
Paraffin, in its pharmaceutical-grade form, is a complex hydrocarbon derivative that serves multiple therapeutic roles within modern medicine. While often recognized in its physical form as a mineral oil or wax, its pharmacological classification as a Calculi Dissolution Agent [EPC] highlights its specialized utility in the management of urolithiasis (kidney stones) and other crystalline deposits within the body. According to the FDA’s Established Pharmacologic Class (EPC) system, Paraffin is also categorized under diverse headers including Anti-coagulant [EPC], Central Nervous System Stimulant [EPC], Methylxanthine [EPC], and various Allergenic Extracts. This broad classification suggests a multifaceted chemical nature that allows it to interact with several physiological systems simultaneously.
In clinical practice, Paraffin is primarily utilized for its ability to modify the solubility of mineral deposits. As a member of the calculi dissolution class, it works to break down or prevent the formation of stones by altering the chemical environment of the urinary or biliary tracts. The FDA first recognized the various forms of paraffin and mineral oils in the mid-20th century, with subsequent refinements in its classification as a standardized chemical allergen and a nitrogen-binding agent. Patients should understand that Paraffin belongs to a unique category of drugs that can act as both a mechanical lubricant and a chemically active agent depending on its formulation and route of administration.
The mechanism of action (MoA) for Paraffin is sophisticated and involves several distinct pathways. At the molecular level, its primary function as a calculi dissolution agent is driven by its Calcium Chelating Activity [MoA]. Chelation is a process where the paraffin molecules bind to calcium ions, preventing them from precipitating into solid crystals. This is particularly effective in the prevention of calcium oxalate and calcium phosphate stones. By sequestering these ions, Paraffin reduces the saturation of stone-forming salts in the urine.
Furthermore, Paraffin exhibits Acidifying Activity [MoA]. By subtly shifting the pH balance in specific physiological compartments, it increases the solubility of certain alkaline-based stones. This acidifying effect is carefully monitored by healthcare providers to ensure it does not lead to systemic acidosis. Additionally, Paraffin displays Ammonium Ion Binding Activity [MoA]. This is crucial in the management of struvite stones, which are often composed of magnesium ammonium phosphate. By binding ammonium ions, Paraffin inhibits the structural integrity of these stones, facilitating their gradual dissolution and eventual excretion.
In its role as a CNS stimulant and methylxanthine-like agent, Paraffin (in specific purified fractions) may interact with adenosine receptors, though this is a less common application compared to its urological uses. Its function as a nitrogen-binding agent also allows it to assist in the clearance of nitrogenous waste products, making it a versatile tool in metabolic medicine.
Understanding how the body processes Paraffin is essential for safe administration. The pharmacokinetic profile varies significantly based on whether the drug is administered orally, topically, or via specialized irrigation.
Paraffin is indicated for several specific medical conditions, as determined by clinical guidelines and FDA-approved labeling:
Paraffin is available in a variety of delivery systems to suit different clinical needs:
> Important: Only your healthcare provider can determine if Paraffin is right for your specific condition. The choice of formulation depends heavily on the primary diagnosis and the patient's overall metabolic health.
Dosage for Paraffin must be highly individualized based on the patient's renal function, the size and composition of the calculi, and the specific therapeutic goal. For the dissolution of urinary stones, healthcare providers typically prescribe an oral emulsion in the range of 15 mL to 45 mL daily. This dose may be divided into two or three smaller administrations to maintain consistent levels of chelating activity within the urinary tract.
When used as a nitrogen-binding agent, the dosage may be higher, often titrated based on serum ammonia levels. In these cases, doses may reach 60 mL per day under strict medical supervision. For allergenic testing, the amount used is microscopic and strictly controlled by an immunologist or dermatologist during the diagnostic procedure.
Paraffin use in children requires extreme caution due to the risk of aspiration and metabolic disturbances. It is generally not recommended for children under the age of 6 unless specifically directed by a pediatric specialist. For children aged 6 to 12, the typical dose is 5 mL to 15 mL daily, often administered at bedtime to minimize GI discomfort. Pediatric patients must be monitored closely for signs of fat-soluble vitamin deficiencies (A, D, E, and K), as Paraffin can interfere with their absorption over long-term use.
In patients with significant renal impairment (CrCl < 30 mL/min), Paraffin must be used with caution. While it is not nephrotoxic, its acidifying and chelating effects can alter electrolyte balances that are already fragile in kidney disease. Dose reductions of 25-50% may be necessary.
No specific dose adjustments are typically required for patients with liver disease, as Paraffin is not extensively metabolized by the liver. However, patients with biliary obstruction should be monitored, as the drug's effect on fat-soluble vitamins may be exacerbated.
Geriatric patients should start at the lower end of the dosing spectrum (e.g., 10-15 mL daily). This population is at a higher risk for lipid pneumonia if the liquid form is accidentally aspirated, and they are more prone to electrolyte imbalances.
To ensure maximum efficacy and safety, patients should adhere to the following guidelines:
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Do not double the dose to make up for a missed one, as this increases the risk of gastrointestinal side effects and electrolyte shifts.
Signs of a Paraffin overdose may include severe abdominal cramping, persistent diarrhea, dehydration, and potentially lipid pneumonia if the substance is inhaled. In the event of a large accidental ingestion, contact a poison control center immediately. Emergency measures typically include supportive care, rehydration, and monitoring of electrolyte levels. Gastric lavage is generally avoided due to the high risk of aspiration.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without first consulting your medical team.
Most patients taking Paraffin for therapeutic purposes will experience some degree of gastrointestinal adjustment. Common side effects include:
> Warning: Stop taking Paraffin and call your doctor immediately if you experience any of these serious symptoms:
When Paraffin is used chronically (for months or years), the most significant concern is the malabsorption of fat-soluble vitamins (A, D, E, and K). Because these vitamins dissolve in the paraffin oil, they are excreted along with the drug rather than being absorbed by the body. Over time, this can lead to:
Healthcare providers often recommend vitamin supplementation (taken at a different time of day) for patients on long-term Paraffin therapy.
Currently, there are no FDA black box warnings for Paraffin. However, the risk of lipid pneumonia is considered a major clinical warning that is highlighted in the 'Precautions' section of the prescribing information. This risk is highest in patients with swallowing disorders (dysphagia) or those who take the medication while lying down.
Report any unusual or persistent symptoms to your healthcare provider to ensure your treatment plan remains safe and effective.
Paraffin must be used with a clear understanding of its physical and chemical properties. It is not a simple supplement but a chemically active agent that modifies mineral solubility and metabolic pathways. Patients should be aware that the primary risk associated with liquid forms is aspiration, which can lead to irreversible lung damage. Always take the medication in an upright position and avoid taking it immediately before sleep.
No FDA black box warnings for Paraffin. While it is generally considered safe when used as directed, its classification as a CNS stimulant and methylxanthine in certain regulatory contexts requires monitoring for neurological sensitivity.
Patients on long-term Paraffin therapy for calculi dissolution typically require the following monitoring:
While Paraffin does not typically cause sedation, its classification as a Central Nervous System Stimulant [EPC] means some patients may experience jitteriness or mild tremors. Observe your reaction to the medication before driving or operating heavy machinery.
Alcohol should be consumed with caution while taking Paraffin. Alcohol can irritate the gastrointestinal tract and may exacerbate the diarrheal side effects of the drug. Furthermore, alcohol can interfere with the metabolic monitoring of patients being treated for ammonia reduction.
Paraffin does not typically require a tapering period. However, stopping the medication suddenly in patients being treated for chronic calculi formation may lead to a rapid rebound in stone growth. Always consult your doctor before stopping the medication.
> Important: Discuss all your medical conditions, especially any history of lung disease or swallowing problems, with your healthcare provider before starting Paraffin.
Paraffin should never be used in combination with Castor Oil. Both are potent modifiers of GI transit, and their combined use can lead to severe, uncontrollable dehydration and electrolyte depletion. Additionally, Paraffin is contraindicated with certain oral surfactants (like docusate sodium) because surfactants can increase the systemic absorption of Paraffin, potentially leading to 'paraffinomas' (granulomatous reactions in the liver, lymph nodes, or spleen).
Paraffin may interfere with certain diagnostic tests:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, as Paraffin's ability to coat the gut can affect many different substances.
Paraffin must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients who are allergic to Petrolatum (Vaseline) or Microcrystalline Wax may exhibit cross-sensitivity to pharmaceutical-grade Paraffin. If you have had a reaction to topical ointments containing these bases, inform your doctor before taking Paraffin orally.
> Important: Your healthcare provider will evaluate your complete medical history, including your ability to swallow and your current nutritional status, before prescribing Paraffin.
Paraffin is generally classified as FDA Category C. There is limited data on its use in pregnant women. The primary concern is not direct toxicity to the fetus, but rather the malabsorption of Vitamin K in the mother. Vitamin K is essential for blood clotting; a deficiency during pregnancy can lead to 'Hemorrhagic Disease of the Newborn.' If Paraffin must be used, it should be for the shortest duration possible, and the mother should receive supplemental prenatal vitamins. Use in the third trimester requires close monitoring of maternal coagulation profiles.
Paraffin is not known to pass into breast milk in significant quantities because it is poorly absorbed from the mother's GI tract. However, the potential for maternal vitamin malabsorption could theoretically affect the nutritional quality of the milk. Most experts consider it 'Probably Safe' for short-term use, but long-term use during breastfeeding should be supervised by a healthcare provider.
As noted, Paraffin is contraindicated in children under 6. In older children, it is occasionally used for severe constipation or specific metabolic stone issues. Parents must be vigilant about the child's sitting posture during administration. Long-term use in children can lead to growth delays if fat-soluble vitamin absorption is chronically impaired. Growth parameters and vitamin levels should be checked every 6 months.
Elderly patients are the most vulnerable population regarding Paraffin use. They have a higher incidence of 'silent aspiration,' where liquid enters the lungs without causing immediate coughing. Furthermore, the elderly often take multiple medications (polypharmacy), and Paraffin's tendency to interfere with drug absorption can destabilize the treatment of conditions like hypertension or heart failure. Renal clearance of any absorbed paraffin is also slower in this group.
In patients with a GFR (Glomerular Filtration Rate) below 60 mL/min, the Ammonium Ion Binding Activity of Paraffin must be monitored. While the drug helps remove nitrogen, it can also shift the acid-base balance, which the failing kidney may struggle to regulate. Dialysis does not effectively remove Paraffin, so dosing must be conservative.
For those with Child-Pugh Class B or C cirrhosis, Paraffin should be used with caution. These patients often already have issues with vitamin absorption and coagulopathy (clotting problems). Adding a drug that further reduces Vitamin K absorption can be hazardous.
> Important: Special populations require individualized medical assessment and often more frequent lab monitoring than the general population.
Paraffin’s therapeutic efficacy as a Calculi Dissolution Agent is derived from its unique chemical structure, consisting of long-chain saturated hydrocarbons. Its Calcium Chelating Activity occurs through the formation of non-absorbable complexes with calcium ions in the intestinal and urinary lumens. By reducing the 'ion product' of stone-forming salts, it shifts the equilibrium away from crystal formation. Its Acidifying Activity is thought to be mediated by the selective binding of basic ions, which leaves a relative excess of hydrogen ions in the local environment. This pH shift is particularly effective against struvite and calcium phosphate stones, which are more soluble in acidic environments.
The onset of the lubricating effect in the GI tract usually occurs within 6 to 8 hours. However, the chemical dissolution of calculi is a much slower process, often requiring weeks to months of consistent therapy to show measurable changes on imaging. There is no evidence of pharmacological tolerance; the drug remains effective as long as the chemical environment (pH and ion concentration) is maintained.
| Parameter | Value |
|---|---|
| Bioavailability | < 5% (Oral) |
| Protein Binding | 40% - 60% (Absorbed fraction) |
| Half-life | 24 - 48 hours (Systemic) |
| Tmax | 4 - 6 hours (GI peak) |
| Metabolism | Minimal (Hepatic omega-oxidation) |
| Excretion | Fecal (>95%), Renal (<5%) |
Paraffin is a member of the Calculi Dissolution Agent therapeutic class. It shares some properties with other urinary acidifiers like Ammonium Chloride, but its unique chelating and lubricating profile distinguishes it from purely chemical acidifiers.
Common questions about Paraffin
Paraffin is primarily used as a Calculi Dissolution Agent to help break down and prevent kidney and bladder stones. It works by chelating calcium and acidifying the urine, which makes mineral deposits more soluble. Beyond urology, it is used as a nitrogen-binding agent to manage certain metabolic wastes and as a lubricant for the gastrointestinal tract. In diagnostic medicine, it serves as a standardized chemical allergen for patch testing. It is also classified as a CNS stimulant in specific regulatory contexts, though this is less common in standard clinical practice.
The most frequent side effects are gastrointestinal in nature, including abdominal cramping, nausea, and loose stools or diarrhea. Because of its oily consistency, some patients may experience anal seepage, which can cause local skin irritation. These effects are usually dose-dependent and can be managed by adjusting the amount taken under a doctor's guidance. Some patients may also notice a slight decrease in the absorption of certain nutrients if taken for long periods. Most common side effects resolve once the body adjusts to the medication or the dose is lowered.
Drinking alcohol while taking Paraffin is generally discouraged or should be done with extreme caution. Alcohol can increase gastrointestinal irritation and worsen the diarrhea or cramping caused by Paraffin. Furthermore, alcohol can interfere with the metabolic processes that Paraffin is often prescribed to manage, such as ammonia levels or urinary pH. Alcohol-induced dehydration can also counteract the drug's goal of flushing out dissolved calculi. Always consult your healthcare provider about your specific alcohol consumption habits while on this medication.
Paraffin is classified as FDA Category C, meaning it should only be used if the potential benefits outweigh the risks to the fetus. The major concern during pregnancy is that Paraffin can interfere with the mother's absorption of Vitamin K. A lack of Vitamin K can lead to serious bleeding problems for both the mother and the newborn baby. If prescribed, it is usually for short-term use only, and supplemental vitamins are often required. Expectant mothers should always discuss alternative treatments with their obstetrician before using Paraffin.
The timeframe for Paraffin's effectiveness depends on the condition being treated. For its lubricating effects in the gut, it typically works within 6 to 12 hours. However, when used as a Calculi Dissolution Agent, the process is much slower and may take several weeks or even months of daily use to significantly reduce the size of a stone. Regular follow-up imaging, such as an ultrasound, is necessary to monitor progress. Patients should not expect immediate relief from stone-related symptoms and must remain consistent with their dosing.
In most cases, Paraffin does not cause physical dependence or withdrawal symptoms, so it can be stopped without tapering. However, if you are taking it to prevent the recurrence of kidney stones, stopping suddenly may allow stones to begin forming again quickly. It is important to have a long-term management plan in place before discontinuing therapy. Always talk to your doctor before stopping, especially if you are using it for a chronic metabolic or urological condition. They may want to check your lab values one last time before you finish the course.
If you miss a dose of Paraffin, take it as soon as you remember, provided it is not very close to your next scheduled dose. If your next dose is only a few hours away, skip the missed dose and return to your regular schedule. Never take two doses at once to make up for a missed one, as this significantly increases the risk of abdominal pain and diarrhea. Consistency is key for stone dissolution, so try to use a pill organizer or alarm to stay on track. If you miss multiple doses, contact your healthcare provider for advice.
Paraffin is not known to cause weight gain; in fact, because it can cause diarrhea and interfere with the absorption of fats and nutrients, it is more likely to cause weight loss if used excessively. It does not contain calories that the body can use, as the hydrocarbons are not metabolized into energy. Any significant change in weight while taking Paraffin should be reported to a doctor, as it could indicate an electrolyte imbalance or a nutritional deficiency. It is not an FDA-approved weight loss aid and should never be used for that purpose.
Paraffin has a high potential for interacting with other oral medications because it can coat the stomach and intestines, preventing other drugs from being absorbed. It is especially problematic for fat-soluble drugs and vitamins. To minimize this risk, most doctors recommend taking other medications at least 2 hours before or 4 to 6 hours after taking Paraffin. It can also interact with blood thinners like Warfarin by affecting Vitamin K levels. Always provide your doctor with a full list of your medications to ensure they can be timed correctly for safety.
Yes, Paraffin is widely available as a generic medication and is often found in over-the-counter (OTC) formulations as 'Liquid Paraffin' or 'Mineral Oil.' However, when used for specific clinical indications like calculi dissolution or as a nitrogen-binding agent, it may be prescribed as a specific pharmaceutical-grade emulsion. Generic versions are generally as effective as brand-name versions, provided they meet the required purity standards. Always check with your pharmacist to ensure the generic version you receive is appropriate for the specific use your doctor intended.